CTMX
CytomX Therapeutics Inc
2.60$
-2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.0 | 9.2 | 7.4 | 2.5 | 1.3 | 6.2 | 18.8 | – | – | – | |
| 53.0 | 26.7 | 25.8 | 18.9 | 13.2 | 11.4 | 14.9 | 10.3 | 10.8 | 11.5 | 6.5 | 8.1 | 5.5 | 6.6 | 4.7 | 4.5 | 3.4 | 3.0 | 7.0 | 6.2 | 5.0 | 4.0 | 2.8 | 2.0 | 1.9 | 2.0 | 1.5 | 1.4 | 1.1 | 1.1 | 1.5 | 0.9 | 0.8 | 0.6 | 0.4 | 2.1 | 4.6 | 9.6 | 23.4 | 45.5 | |
| 6.4 | 5.1 | 8.6 | 10.9 | 14.8 | 11.7 | 22.2 | 21.7 | 5.2 | 5.2 | 4.0 | 5.0 | 4.1 | 7.4 | 5.2 | 6.5 | 6.4 | – | 3.2 | 3.1 | 3.0 | – | 2.6 | 2.4 | 3.5 | – | – | – | – | – | – | – | – | – | 2.2 | 2.5 | 4.9 | 7.4 | 2.6 | 2.8 | |
| 47.5 | 19.8 | 22.3 | 9.9 | 7.6 | 8.9 | 13.0 | 8.8 | 7.4 | 7.5 | 4.4 | 5.8 | 2.9 | 3.4 | 2.9 | 1.1 | 1.5 | 1.2 | 2.1 | 2.4 | 1.5 | 1.1 | 0.3 | -0.1 | 0.1 | -1.6 | 0.7 | 0.8 | 0.9 | 0.9 | 1.3 | 0.5 | 0.5 | 0.3 | 0.1 | 1.8 | 4.4 | 9.5 | 22.7 | 44.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 18.7 | 11.5 | 6.2 | 3.5 | 3.9 | 1.4 | 0.3 | 5.1 | 16.9 | – | – | – | |
| – | – | – | 4.1 | 4.5 | 4.8 | 6.3 | – | – | – | – | – | – | – | – | – | – | 103.4 | 20.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.4% | -1.0% | -2.9% | 24.4% | 22.1% | 20.7% | 15.8% | -3.0% | -3.4% | -11.6% | -21.5% | -24.9% | -42.7% | -37.9% | -42.5% | -2.1% | -3.0% | 1.0% | 4.9% | -25.0% | -32.2% | -43.0% | -74.6% | -117.1% | -144.0% | -106.2% | -61.6% | -46.2% | -34.4% | -52.8% | -50.8% | -84.7% | -86.8% | -108.0% | -147.2% | -26.2% | -13.7% | -10.4% | -9.6% | -9.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.9% | 97.6% | 97.5% | 94.4% | 97.2% | 95.6% | 94.3% | 95.3% | 95.6% | 97.5% | 98.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.3% | 98.6% | |
| -528.7% | -396.1% | -212.6% | -209.5% | -116.6% | -64.6% | -71.8% | -47.5% | -71.0% | -130.9% | -105.4% | -154.9% | -163.7% | -192.9% | -125.2% | -96.3% | -77.2% | -48.4% | -92.1% | -97.1% | -109.1% | -120.4% | -160.0% | -187.6% | -223.9% | -190.6% | -110.8% | -60.7% | -7.8% | 1.5% | 15.8% | 11.5% | 5.3% | 18.1% | 24.4% | 30.6% | 20.5% | -29.4% | -181.9% | -476.2% | |
| -523.8% | -391.5% | -208.9% | -206.3% | -113.6% | -60.2% | -67.9% | -44.5% | -68.9% | -142.2% | -111.3% | -158.1% | -163.2% | -177.8% | -97.8% | -73.5% | -58.1% | -32.8% | -90.9% | -96.7% | -108.9% | -120.2% | -159.7% | -186.3% | -221.3% | -186.8% | -104.5% | -53.1% | -10.7% | -0.6% | 13.9% | 9.3% | 10.9% | 23.1% | 28.2% | 34.0% | 24.7% | -22.8% | -166.4% | -435.2% | |
| -129.1% | -28.0% | -75.1% | 461.8% | 292.0% | 235.7% | 234.0% | -31.0% | -36.9% | -133.3% | -140.1% | -202.2% | -236.7% | -250.4% | -198.3% | -9.2% | -10.1% | 2.9% | 34.2% | -154.4% | -161.7% | -173.4% | -210.3% | -233.3% | -269.8% | -211.7% | -90.5% | -65.7% | -38.2% | -56.2% | -77.5% | -72.2% | -70.1% | -62.7% | -55.3% | -55.1% | -63.7% | -99.5% | -225.6% | -450.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -63.0% | -75.1% | -69.3% | -119.0% | -127.0% | -61.7% | -101.4% | -93.8% | -32.8% | -64.6% | -67.9% | -97.3% | -120.6% | -200.0% | -108.8% | -106.5% | -111.6% | – | -41.5% | -49.0% | -64.5% | – | -146.7% | -226.4% | -410.1% | – | – | – | – | – | – | – | – | – | 166.1% | 40.0% | 26.1% | -17.5% | -18.5% | -26.4% | |
| -29.2% | -29.6% | -28.7% | -17.7% | -14.9% | -10.8% | -13.4% | -10.2% | -10.7% | -18.5% | -18.7% | -24.4% | -26.6% | -30.0% | -17.4% | -15.6% | -14.3% | -9.2% | -14.0% | -16.0% | -19.4% | -24.6% | -33.7% | -42.4% | -51.6% | -38.1% | -30.1% | -20.2% | -4.6% | -0.3% | 9.0% | 7.0% | 10.0% | 26.4% | 42.2% | 27.4% | 17.7% | -11.5% | -16.5% | -20.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -60 | -105 | -86 | -273 | -284 | -178 | -141 | -130 | -255 | -234 | -161 | -147 | -162 | -186 | -140 | -288 | -174 | -189 | -326 | -253 | -233 | -202 | -160 | -125 | -91 | -190 | -52 | -53 | -22 | -13 | -31 | -38 | -36 | -33 | -42 | -44 | -29 | -8.4 | -26 | -16 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.8 | -1.5 | -1.3 | -2.1 | -2.1 | -1.0 | -1.0 | -0.9 | -1.0 | – | – | – | |
| 46.4% | 39.4% | 41.5% | 14.8% | 11.8% | 17.6% | 13.2% | 10.9% | 32.7% | 28.6% | 27.6% | 25.0% | 22.0% | 15.0% | 16.0% | 14.6% | 12.8% | -2.2% | 33.6% | 32.5% | 30.1% | -0.1% | 23.0% | 18.7% | 12.6% | -32.9% | -36.9% | -40.6% | -23.2% | -23.5% | -17.2% | -19.6% | -16.9% | -0.4% | 25.4% | 68.5% | 67.9% | 65.3% | 89.0% | 79.2% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | – | 0.0 | 0.0 | 0.0 | – | 0.1 | 0.1 | 0.1 | – | – | – | – | – | – | – | – | – | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.55 | -1.61 | -1.40 | -1.69 | -1.56 | -1.12 | -1.30 | -0.99 | -1.18 | -1.87 | -1.84 | -2.18 | -2.18 | -2.24 | -1.61 | -1.36 | -1.16 | -0.71 | -0.99 | -0.99 | -1.11 | -1.28 | -1.53 | -1.68 | -1.77 | -1.50 | -1.07 | -0.63 | -0.13 | -0.01 | 0.20 | 0.13 | 0.16 | 0.40 | 0.48 | 0.37 | 0.17 | -0.10 | -0.33 | -0.36 | |
| 0.30 | 0.41 | 0.67 | 0.82 | 1.38 | 1.85 | 1.92 | 2.23 | 1.71 | 1.32 | 1.66 | 1.38 | 1.34 | 1.26 | 1.65 | 1.85 | 2.00 | 2.17 | 1.09 | 1.02 | 1.02 | 1.07 | 0.96 | 0.90 | 0.80 | 0.80 | 1.02 | 1.19 | 1.17 | 1.50 | 1.44 | 1.41 | 1.49 | 1.72 | 1.69 | 1.09 | 0.69 | 0.45 | 0.20 | 0.08 | |
| 2.46 | 2.15 | 2.02 | 1.42 | 1.23 | 1.81 | 1.28 | 1.06 | 3.59 | 2.90 | 2.72 | 2.24 | 1.81 | 1.12 | 1.48 | 1.28 | 1.04 | -0.17 | 2.40 | 2.01 | 1.71 | -0.01 | 1.04 | 0.74 | 0.43 | -1.29 | -1.31 | -1.28 | -0.63 | -0.70 | -0.38 | -0.37 | -0.28 | -0.01 | 0.29 | 0.93 | 0.65 | 0.58 | 1.80 | 1.38 | |
| -0.38 | -0.12 | -0.50 | 3.78 | 4.02 | 4.37 | 4.49 | -0.69 | -0.63 | -1.76 | -2.32 | -2.79 | -3.16 | -3.15 | -3.27 | -0.17 | -0.20 | 0.06 | 0.37 | -1.58 | -1.64 | -1.85 | -2.01 | -2.11 | -2.16 | -1.70 | -0.92 | -0.78 | -0.45 | -0.84 | -1.12 | -1.02 | -1.04 | -1.08 | -0.94 | -0.60 | -0.44 | -0.45 | -0.45 | -0.38 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.